IP Library Granted Patent US 10,688,260
Granted Patent B2
US 10,688,260 · App. 15/761,736 · Granted Jun 23, 2020

Devices and systems for air assisted dry powder administration

Inventors: Jeffrey Gjertsen (Austin, TX); Phillip Goodman (Austin, TX); Jesse Hancock (Cedar Park, TX); Michael Shaw (Austin, TX); Timothy Sullivan (Austin, TX)
Assignee: Mystic Pharmaceuticals, Inc.
A61M15/004A61M15/0005A61M15/009A61M15/0035A61M15/0061A61M16/14B65D75/328B65D75/368B65D75/70B65D83/06A61M15/0008A61M15/0036A61M2202/0266A61M2202/064B65D2221/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,688,260
App. No.
15/761,736
Granted
Jun 23, 2020
Kind
B2
Abstract

The multi-chambered well dosage form and device disclosed herein can be single or multi dose capable for administration of pharmaceuticals of a range of particle sizes. The present dosage devices and systems provide for improved efficiency and patient ease of use owing to its compact size and simple design, low cost, and consistent, contamination free dosing of dry powder medicaments or other agents. The present disclosure provides a multi-chambered dosage form containing dry powder medical composition containing chamber well with an internal piercing device and one or more adjacent gas-filled chamber wells to aid the dispense of the powder contents to the user and in certain embodiments, without the requirement of an external energy sources common with active devices known in the art. Said methods, systems and devices provide increased ejection fraction and hence greater efficiency of drug delivery above that as provided by current devices.

Claims (27)

1. A dry powder unit dose device, comprising:

a dosage form comprising more than one blister well;

wherein a blister well contains an internal piercing device and a dry powder, and at least one additional-blister well contains a gas propellant;

wherein the at least one propellant containing blister well is in fluid communication with said powder containing blister well upon rupture of a frangible sealed interface between the propellant containing blister well and the powder containing blister well;

wherein the internal piercing device further comprises a base and an elongated piercing member wherein the elongated piercing member further comprises a flow directing channel oriented axially upon the base such that it is substantially opposite an inflow of propellant; and

wherein the flow directing channel of the internal piercing device is horizontally positioned on the base substantially off center and substantially opposite an end of the blister well where propellant flows into the powder containing blister well during dispense.

2. The dry powder unit dose device of claim 1 , wherein the frangible sealed interface between the gas and powder containing blister wells further comprises an elongated path channel.

3. The dry powder unit dose device of claim 1 wherein the gas propellant is nitrogen.

4. A delivery system for administering a dry powder substance to a subject, comprising:

a handheld dispensing device;

a dosage form comprising more than one blister well;

wherein a blister well contains an internal piercing device and a dry powder, and at least one additional blister well contains a gas propellant;

wherein the at least one propellant containing blister well is in fluid communication with said powder containing blister well upon rupture of a sealed interface between the propellant containing blister well and the powder containing blister well; and

wherein the internal piercing device further comprises a base and an elongated piercing member wherein the elongated piercing member further comprises a flow directing channel oriented axially upon the base such that it is substantially opposite an inflow of propellant and is horizontally positioned on the base substantially off center and substantially opposite an end of the blister well where propellant flows into the powder containing blister well during dispense.

5. The delivery system of claim 4 , wherein the sealed interface between the gas and powder containing blister wells of the dosage form further comprises an elongated path channel.

6. The delivery system of claim 4 , wherein the dosage form further comprises a pinching mechanism configured to provide the sealed interface between the gas and powder containing blister wells.

7. The delivery system according to claim 4 , wherein the gas propellant is nitrogen.

8. The delivery system of claim 4 , wherein the handheld dispensing device further comprises an actuator mechanism configured to sequentially time the compression of the blister wells.

9. The delivery system of claim 8 , wherein the dispensing device actuator mechanism further comprises an electromechanical device.

10. The delivery system of claim 4 , wherein the dispensing device further comprises a serrated surface upon a device component.

11. The delivery system of claim 1 , wherein the dosage form further comprises a pinching mechanism configured to provide the sealed interface between the gas and powder containing blister wells.

12. A dry powder unit dose device, comprising:

a dosage form comprising more than one blister well;

wherein a first blister well contains an internal piercing device, a second blister well contains a dry powder, and at least one additional-blister well contains a gas propellant;

wherein the at least one propellant containing blister well is in fluid communication with said powder containing blister well upon rupture of a sealed interface between the propellant containing blister well and the powder containing blister well;

wherein the internal piercing device further comprises a base and an elongated piercing member wherein the elongated piercing member further comprises a flow directing channel oriented axially upon the base such that it is substantially opposite an inflow of propellant; and

wherein the flow directing channel of the internal piercing device is horizontally positioned on the base substantially off center and substantially opposite an end of the first blister well.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2024
From: MYSTIC PHARMACEUTICALS, INC.
To: INFUSE, LLC
Reel/Frame 067218/0332 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2018
From: GJERTSEN, JEFF; GOODMAN, PHILLIP; HANCOCK, JESSE; SHAW, MICHAEL; SULLIVAN, TIMOTHY
To: MYSTIC PHARMACEUTICALS, INC
Reel/Frame 046434/0754 →
Continuity (2)
Provisional Application 62222861 · Sep 24, 2015
Related Publication 20190060587A1 · Feb 28, 2019